Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 58Gynecologic 7Genitourinary 7Thoracic 6Breast 4Sarcoma 2Head & Neck 2Endocrine 2Dermatologic 2CNS 2Plasma cell 1Other solid neoplasm 1Other hematologic neoplasm 1

Conditions

Melanoma 688Lymphoma, T-Cell, Cutaneous 116Keratosis, Actinic 109Skin Neoplasms 99Carcinoma, Non-Small-Cell Lung 81Mycosis Fungoides 79Neoplasm Metastasis 78Neoplasms 75Sezary Syndrome 74Lymphoma, Non-Hodgkin 72Leukemia, Lymphocytic, Chronic, B-Cell 65Lymphoma, Follicular 64Lymphoma, Large B-Cell, Diffuse 63Lymphoma, B-Cell, Marginal Zone 60Precursor Cell Lymphoblastic Leukemia-Lymphoma 59Lymphoma, Mantle-Cell 59Uveal Melanoma 58Carcinoma, Renal Cell 58Carcinoma, Basal Cell 58Lymphoma, Large-Cell, Immunoblastic 56Hodgkin Disease 56Burkitt Lymphoma 55Lymphoma 52Lymphoma, Large-Cell, Anaplastic 50Waldenstrom Macroglobulinemia 44Multiple Myeloma 44Lymphoma, Extranodal NK-T-Cell 44Breast Neoplasms 44Immunoblastic Lymphadenopathy 43Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 41

Interventions

pembrolizumab 1milademetan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Biliary Tract Neoplasms × Dermatologic × Clear all
NCT04234113 2026-03-27

Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors

Sotio Biotech Inc.

Phase 1 Terminated
115 enrolled 43 charts
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Melanoma, Mesothelioma, Ovarian Neoplasms, Stomach Neoplasms, Thymus Neoplasms, Thyroid Neoplasms, Carcinoma, Merkel Cell, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT05012397 2024-10-17

Milademetan in Advanced/Metastatic Solid Tumors

Rain Oncology Inc

Phase 2 Terminated
40 enrolled 13 charts
DermatologicEndocrineGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Testicular Germ Cell Tumor, Adenocarcinoma of Lung, Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Adrenocortical Carcinoma, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡